LDLR rs121918405: Understanding This Rare Genetic Variant

What each genotype means

What is rs121918405?

The identifier rs121918405 refers to a specific single nucleotide polymorphism (SNP) located within the LDLR gene. In genetics, a SNP represents a variation at a single position in the DNA sequence. This particular variant is classified as rare, meaning it is not commonly found in the general population. It sits within the coding region of the LDLR gene, which provides the blueprint for the low-density lipoprotein receptor protein. Because this variant is located in a critical gene responsible for lipid metabolism, researchers monitor it closely to understand how it might alter the structure or function of the resulting protein. Geneticists use these identifiers to track specific locations on the human genome, allowing for consistent study across different research institutions and clinical databases worldwide.

The Role of the LDLR Gene

The LDLR gene is essential for maintaining healthy cholesterol levels in the blood. It encodes the low-density lipoprotein receptor, a protein that sits on the surface of cells, particularly in the liver. This receptor acts like a docking station, binding to low-density lipoprotein (LDL) particles—the primary carriers of cholesterol—and pulling them out of the bloodstream and into the cell through a process called endocytosis. Once inside the cell, the cholesterol is processed or stored, which effectively lowers the amount of LDL cholesterol circulating in the blood. When the LDLR gene functions normally, it helps keep cholesterol levels within a healthy range. If the gene contains a pathogenic variant, the receptors may be produced incorrectly, fail to reach the cell surface, or lose their ability to bind to LDL particles, leading to higher levels of cholesterol in the blood.

Research and Clinical Associations

Scientific research associates variants in the LDLR gene with familial hypercholesterolemia, a condition characterized by significantly elevated levels of LDL cholesterol and an increased risk of premature cardiovascular disease. The evidence for the pathogenicity of specific variants in LDLR is often curated by clinical genetics consortia. While some variants have definitive evidence of causing disease, others are classified as variants of uncertain significance as more data is gathered. The rs121918405 variant is noted in clinical catalogs for its potential to disrupt normal cholesterol clearance. Because this variant is rare, clinical studies often rely on functional assays—laboratory tests that observe how the mutant protein behaves in cell cultures—to determine its impact. These studies help researchers understand the mechanism by which the variant contributes to lipid metabolism issues, though the clinical expression of such variants can vary significantly between individuals.

Population Frequency

The rs121918405 variant is considered rare across global populations. Because it is not a common polymorphism, it is not typically found in the majority of the population. Frequency data is derived from large-scale genomic databases like gnomAD, which aggregate genetic information from diverse ancestries to determine how often a specific allele appears. For rare variants, the frequency is often so low that it may be absent in many population subsets. This rarity is a hallmark of many pathogenic variants associated with inherited metabolic conditions, as these changes are often subject to selective pressure. Researchers continue to study these rare variants to better understand the full spectrum of genetic diversity and its impact on human health.

Managing Genetic Information

If you have received information about a rare variant like rs121918405, it is important to understand what this means for your health. Genetic variants are only one piece of a complex puzzle that includes diet, lifestyle, and other genetic factors. This information should never be used to self-diagnose or make medical decisions. If you are concerned about your cholesterol levels or cardiovascular risk, the most appropriate step is to consult with a healthcare provider or a genetic counselor. They can interpret your results in the context of your personal and family medical history. If you are currently taking medication to manage cholesterol, do not change your dosage or stop treatment without discussing it with your clinician or pharmacist. They are the best resources for creating a personalized health plan based on your specific clinical needs.

Frequently asked questions

Sources & further reading

Related variants in LDLR